Insights from 2024 WCLC


 

WCLC 2024 Insights: FLAURA2 Trial - Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemo in EGFR-Mutated Advanced NSCLC

159 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login